SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 149 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $362,000 | +95.7% | 162,236 | +154.4% | 0.01% | +80.0% |
| Q3 2017 | $185,000 | +65.2% | 63,768 | +247.0% | 0.01% | +66.7% |
| Q4 2016 | $112,000 | +12.0% | 18,376 | +1.3% | 0.00% | +50.0% |
| Q3 2016 | $100,000 | -23.7% | 18,144 | -47.2% | 0.00% | -33.3% |
| Q2 2016 | $131,000 | -1.5% | 34,385 | -28.6% | 0.00% | 0.0% |
| Q1 2016 | $133,000 | +6.4% | 48,161 | +118.2% | 0.00% | -25.0% |
| Q4 2015 | $125,000 | -44.4% | 22,074 | -48.1% | 0.00% | -50.0% |
| Q3 2015 | $225,000 | -51.1% | 42,506 | -23.3% | 0.01% | -38.5% |
| Q2 2015 | $460,000 | +767.9% | 55,415 | +381.2% | 0.01% | +550.0% |
| Q1 2015 | $53,000 | – | 11,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |